Back to results

Department of Oncology, Clinical Sciences, Lund University

FDG-PET in Cervical Cancer - Translational Studies

Abstract

dc:description

Cervical cancer is the second most common cancer in females. The treatment, based on clinical FIGO stage, carries a significant risk of side effects. FDG-PET enables non-invasive studies of glucose metabolism. Cancer cells show an increased glucose uptake and metabolism that can be visualised and further analysed. The aims of this thesis were to evaluate FDG-PET in the clinical management of cervical cancer and to experimentally investigate the metabolic changes in a tumour following cytotoxic treatment. In a prospective study we found that FDG-PET provided important information about the extent of the disease in primary staging of locally advanced cases and in re-staging of recurrent disease. The treatment plans were altered as a result of the FDG-PET findings for one fourth of the patients. Surveillance FDG-PET 6 months after surgery for early-stage disease showed no clinical value. With a predictive FDG-PET early during radiotherapy for locally advanced disease we could identify a group of patients with an excellent prognosis. However, for the majority of the patients early prediction of outcome was not possible. Persisting hypermetabolism on FDG-PET 3 months after completed radiotherapy was associated with relapse. Experimentally, we found a transient metabolic flare in xenografted tumours on day 1 following cisplatin exposure. A metabolic flare in squamous cell carcinoma cells in vitro was found to be an early sign of response to cisplatin treatment. No increase in metabolism was detected in fibroblasts in vitro or in reactive cells in vivo. In conclusion, we have demonstrated a clinical value of FDG-PET in the management of cervical cancer, and in an experimental setting we have increased the understanding of tumour metabolism.

Degree

thesis:*
Grantor dc:publisher
Department of Oncology, Clinical Sciences, Lund University
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bjurberg, Maria

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
urn:isbn:978-91-86443-65-8
OAI identifier oai:identifier
oai:lup.lub.lu.se:a9f3c13c-5dfc-4df7-a11b-f4b1e0a19b73

Chain of custody

source
Harvested from
University of Lund
Base URL
lup.lub.lu.se/oai
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Bjurberg, Maria. FDG-PET in Cervical Cancer - Translational Studies. Department of Oncology, Clinical Sciences, Lund University, 2010. https://lup.lub.lu.se/record/1580925